Covid has made biotech companies the hot new tech sector as investor demand drives record IPOs

Increased interest in the mRNA technology used to make Covid vaccines has driven a lot of capital into biotech stocks, fueling record financings and IPOs.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.